Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Alobresib is an inhibitor of bromodomain and extra-terminal domain (BET) proteins.1,2 It inhibits proliferation of MEC-1 chronic lymphocytic leukemia cells (CLL; IC50 = 46.4 nM).1 Alobresib (400 nM) decreases the levels of Blk and Myc and increases the levels of IκBα in patient-derived CLL cells co-cultured with nurse-like cells (NLC). It inhibits proliferation of USPC-ARK-1 and USPC-ARK-2 uterine serous carcinoma (USC) cells with IC50 values of 31 and 27 nM, respectively.2 Alobresib (10 and 20 mg/kg, p.o.) reduces tumor growth in a USPC-ARK-2 USC mouse xenograft model.
WARNING This product is not for human or veterinary use.
1. The BET inhibitor GS-
2. Inhibition of BET bromodomain proteins with GS-